Kojiro Hata

529 total citations
30 papers, 347 citations indexed

About

Kojiro Hata is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kojiro Hata has authored 30 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Epidemiology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kojiro Hata's work include Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Kojiro Hata is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Kojiro Hata collaborates with scholars based in Japan and United States. Kojiro Hata's co-authors include Yoichi Nakanishi, Kimitaka Suetsugu, Nobuaki Egashira, Satohiro Masuda, Hiroyuki Watanabe, Akira Murasawa, Fumitake Gejyo, Noriko Saito, Masatoshi Kikuchi and Kiyoshi Nakazono and has published in prestigious journals such as Scientific Reports, Digestive Diseases and Sciences and Cancers.

In The Last Decade

Kojiro Hata

24 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kojiro Hata Japan 9 163 127 124 62 39 30 347
Ankit Mangla United States 10 156 1.0× 52 0.4× 45 0.4× 73 1.2× 37 0.9× 74 332
Gerasimos Baltayiannis Greece 11 65 0.4× 196 1.5× 207 1.7× 72 1.2× 25 0.6× 23 331
Shefali Vyas United States 8 127 0.8× 58 0.5× 39 0.3× 20 0.3× 43 1.1× 16 366
Benjamin Rivière France 9 73 0.4× 112 0.9× 119 1.0× 28 0.5× 25 0.6× 24 305
Burkhardt Ringe Germany 6 170 1.0× 122 1.0× 79 0.6× 101 1.6× 64 1.6× 8 389
Grace Hartman United States 11 158 1.0× 109 0.9× 137 1.1× 45 0.7× 14 0.4× 22 429
Valentina Monti Italy 9 41 0.3× 195 1.5× 195 1.6× 23 0.4× 19 0.5× 17 350
Bora Aktaş Türkiye 9 118 0.7× 119 0.9× 43 0.3× 45 0.7× 17 0.4× 32 311
Masaya Tamano Japan 10 51 0.3× 141 1.1× 150 1.2× 60 1.0× 15 0.4× 66 333
Shigeo Maruyama Japan 9 46 0.3× 188 1.5× 182 1.5× 25 0.4× 8 0.2× 25 378

Countries citing papers authored by Kojiro Hata

Since Specialization
Citations

This map shows the geographic impact of Kojiro Hata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kojiro Hata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kojiro Hata more than expected).

Fields of papers citing papers by Kojiro Hata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kojiro Hata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kojiro Hata. The network helps show where Kojiro Hata may publish in the future.

Co-authorship network of co-authors of Kojiro Hata

This figure shows the co-authorship network connecting the top 25 collaborators of Kojiro Hata. A scholar is included among the top collaborators of Kojiro Hata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kojiro Hata. Kojiro Hata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suetsugu, Kimitaka, Kojiro Hata, Mioko Matsuo, et al.. (2024). Risk Factors of Cetuximab-Induced Hypomagnesemia and the Effect of Magnesium Prophylaxis in Patients with Head and Neck Cancer: A Retrospective Study. Biological and Pharmaceutical Bulletin. 47(3). 732–738. 3 indexed citations
2.
3.
Nakamura, Shôji, Kazuya Tsubouchi, Yasuto Yoneshima, et al.. (2024). Krebs von den Lungen-6 surveillance in immune checkpoint inhibitor-induced pneumonitis. Journal for ImmunoTherapy of Cancer. 12(12). e010114–e010114. 5 indexed citations
4.
Suetsugu, Kimitaka, Kojiro Hata, Satoshi Nakao, et al.. (2023). Systematic surveillance of immune-related adverse events in clinical practice and impact of subsequent steroid medication on survival outcomes. International Journal of Clinical Oncology. 28(7). 860–871. 13 indexed citations
5.
Toshida, Katsuya, Shinji Itoh, Tomoharu Yoshizumi, et al.. (2021). Retrospective evaluation of the effect of Ninjin’yoeito in hepatocellular carcinoma patients treated with lenvatinib. Surgery Today. 52(3). 441–448. 5 indexed citations
6.
Watanabe, Hiroyuki, Kojiro Hata, Kimitaka Suetsugu, et al.. (2021). Prognostic significance of pre-treatment ALBI grade in advanced non-small cell lung cancer receiving immune checkpoint therapy. Scientific Reports. 11(1). 15057–15057. 22 indexed citations
7.
Watanabe, Hiroyuki, Kojiro Hata, Kimitaka Suetsugu, et al.. (2021). Continuous monitoring of neutrophils to lymphocytes ratio for estimating the onset, severity, and subsequent prognosis of immune related adverse events. Scientific Reports. 11(1). 1324–1324. 48 indexed citations
8.
Hotta, T, et al.. (2021). High serum C-reactive protein levels predict survival in patients with treated advanced lung adenocarcinoma. Journal of Thoracic Disease. 13(3). 1476–1484. 5 indexed citations
9.
Tsubata, Yukari, Kojiro Hata, T Hotta, et al.. (2021). Results of 10-year mobile low-dose computed tomography screenings for lung cancer in Shimane, Japan. Respiratory Investigation. 60(2). 215–220. 4 indexed citations
10.
Yoneshima, Yasuto, Kentaro Tanaka, Yoshimasa Shiraishi, et al.. (2019). Safety and efficacy of PD-1 inhibitors in non–small cell lung cancer patients positive for antinuclear antibodies. Lung Cancer. 130. 5–9. 45 indexed citations
11.
Uchida, Mayako, Tsutomu Nakamura, Kojiro Hata, et al.. (2018). Antiemetic efficacy and safety of granisetron or palonosetron alone and in combination with a corticosteroid for ABVD therapy-induced nausea and vomiting. Journal of Pharmaceutical Health Care and Sciences. 4(1). 1–1. 8 indexed citations
12.
13.
Sakai, Fumihiko, et al.. (2010). Marine Traffic Simulation of the Straits of Malacca and Singapore. The Journal of Japan Institute of Navigation. 122(0). 91–96. 1 indexed citations
14.
15.
Ohkoshi, Shogo, Takafumi Ichida, Yasuo Takeda, et al.. (2002). Interferon Inhibits Progression of Liver Fibrosis and Reduces the Risk of Hepatocarcinogenesis in Patients with Chronic Hepatitis C: A Retrospective Multicenter Analysis of 652 Patients. Digestive Diseases and Sciences. 47(1). 170–176. 25 indexed citations
16.
Nakazono, Kiyoshi, Akira Murasawa, Kojiro Hata, et al.. (2001). Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient. Arthritis & Rheumatism. 44(2). 339–342. 80 indexed citations
17.
Igarashi, Kentaro, et al.. (1997). A CASE OF COLLAGENOUS COLITIS WITH A UNIQUE ENDOSCOPIC APPEARANCE. Acta gastro-enterologica belgica. 39(6). 1099–1104. 2 indexed citations
18.
Hata, Kojiro, Showgo Ohkoshi, Minoru Nomoto, et al.. (1992). A case of hepatocellular carcinoma in primary biliary cirrhosis positive for anti-HCV.. Kanzo. 33(2). 167–173. 3 indexed citations
19.
Takahashi, Toru, Takehiko Abe, Takafumi Saito, et al.. (1990). PERITONEOSCOPIC FINDINGS OF ALCOHOLIC LIVER INJURY WITH SPECIAL REFERRENCE TO HISTOLOGICAL CHANGES. Acta gastro-enterologica belgica. 32(6). 1341–1353.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ankit Mangla Breakdown of academic impact, for papers by Gerasimos Baltayiannis Breakdown of academic impact, for papers by Shefali Vyas Breakdown of academic impact, for papers by Benjamin Rivière Breakdown of academic impact, for papers by Burkhardt Ringe Breakdown of academic impact, for papers by Grace Hartman Breakdown of academic impact, for papers by Valentina Monti Breakdown of academic impact, for papers by Bora Aktaş Breakdown of academic impact, for papers by Masaya Tamano Breakdown of academic impact, for papers by Shigeo Maruyama
Rankless by CCL
2026